This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) totaling $381,487 aims to assess the implementation and early effects of long-acting injectable cabotegravir (CAB-LA) for HIV pre-exposure prophylaxis (PrEP) among adolescent girls and young women in Zambia. The "Scaling Comprehensive Access to Long-Acting for Equitable and Effective Use of PrEP (SCALE-UP)" study will use...
The Institute for Public Health Innovation (IPHI) was awarded a $6 million Project Grant from the Department of Health and Human Services Health Resources and Services Administration Bureau of Health Professionals under the Public Health Training Centers Program (CFDA 93.516). The grant will support IPHI's Community Health Worker Academy initiative to develop the community health worker workforce and address health inequities in Washington D.C. and surrounding counties through September 2025....
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $1,251,196 to the University of Washington to scale up an evidence-based Adolescent Transition Package (ATP) to support transitional care for youth living with HIV in Kenya. The ATP is a healthcare worker toolkit that includes educational materials and tracking tools to facilitate the transition process for youth living with HIV as they move from...
The Association de Sante Familiale (ASF) and PATH are implementing the USHINDI project through a $6,749,031 cooperative agreement awarded by the Centers for Disease Control and Prevention under the Global AIDS program (CFDA 93.067), part of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). The project aims to enhance access to comprehensive HIV prevention, care, and treatment services in seven health zones in Haut-Katanga Province, Democratic Republic of the Congo, to contribute to...
This $781,926 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports a research project to develop and pilot test an evidence-based intervention to improve postpartum family planning (PPFP) services in Zambia. The key objectives are to: 1) Evaluate structural- and contextual-level factors influencing healthy birth intervals through stakeholder interviews and...
This $9,358,205 Cooperative Agreement award under the Global AIDS program (CFDA 93.067), funded by the U.S. Centers for Disease Control and Prevention (CDC), aims to strengthen Haiti's health system capacity to achieve HIV epidemic control by 2025. The prime awardee, the Centre Haitien Pour LE Renforcement DU Systeme De Sante (CHARESS), a non-profit organization based in Port-au-Prince, will provide technical assistance to Haiti's Ministry of Health (MSPP) and implementing partners to: 1)...
This Project Grant from the U.S. Department of State Bureau of African Affairs provided $120,179.59 to Ciheb Zambia LIMITED for community-led monitoring to improve the quality of HIV care in Zambia through client feedback. The grant was awarded on April 1, 2021 with a completion date of January 31, 2022. Under the President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029), the grantee and three sub-awardees—Ndekeleni Development Foundation, Youth Development Organisation, and...
This $1,365,212 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program supports the development and testing of a peer-led dynamic choice HIV prevention intervention for women at elevated HIV risk in Uganda. The intervention aims to increase coverage of biomedical HIV prevention products such as oral pre-exposure prophylaxis (PrEP), the dapivirine vaginal ring (DVR), and long-acting cabotegravir (CAB-LA), as well as...
The National Institutes of Health (NIH) is providing a $205,235 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the University of North Carolina at Chapel Hill (UNC-CH) for the "KUPAMBANA" intervention study. The study aims to address intersectional HIV and poverty stigmas and strengthen economic capabilities among young people living with HIV in Zambia, in order to improve HIV care continuum and mental health outcomes. The two-phase project will first adapt...
This Cooperative Agreement award of $150,000 from the U.S. Agency for International Development (USAID) Zimbabwe under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to co-design and document evidence for a scalable private sector HIV/sexual and reproductive health (SRH) prevention service delivery model for most-at-risk young people and key populations through private providers (pharmacies and physicians) in Zimbabwe. The goal is to develop a sustainable,...